Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
It would be good to hear from those who attended the the AGM in person in order to get an idea if the take was any different from those online. Reaction has been very bad so far on this b. No bad news on 1801 but 1802 in the slow lane apparently and 737 apparently stuck. RF, if there was a possibility for a placing was a fundamental error. We'd be interested if there was a glass of mulled wi e and mince pies available after the agm with the possibility of friendly chat with the directors to garner any feelings they might have of talk of progress on 1801, anything on 1802 or any rumours regarding 737 for that matter.
I'm with you there SAD. Had a similar blood sugar diagnosis recently and have also gone on a diet to reduce the blood sugar As I am pre diabetic it is suggested that becoming a diabetic is significantly reduced. I've lost considerable weight by ditchinng white carbs but do take wholegrain carbs for now
Think the trick is sticking to the diet as we tend to slip back as any doctor who deals with dieting for weight loss will tell you. It is suggested that diabetis is an approaching epidemic. I find potatoes the most difficult to avoid as they comein so many different guises.
SAR is unfortunately on the floor pricewise and it's good that the safety indications are looking to be so positive. When do you think k we an get indi actions on the biomarkers as it's something that is less discussed. It would e a great help to get some positive statement on 1801 and sar before the AGM.
Positive statements on 1801 and 737 before and at the AGM
I'm with you there SAD. Had a similar blood sugar diagnosis recently and have also gone on a diet to reduce the blood sugar As I am pre diabetic it is suggested that becoming a diabetic is significantly reduced. I've lost considerable weight by ditchinng white carbs but do take wholegrain carbs for now
Think the trick is sticking to the diet as we tend to slip back as any doctor who deals with dieting for weight loss will tell you. It is suggested that diabetis is an approaching epidemic. I find potatoes the most difficult to avoid as they comein so many different guises.
SAR is unfortunately on the floor pricewise and it's good that the safety indications are looking to be so positive. When do you think k we an get indi actions on the biomarkers as it's something that is less discussed. It would e a great help to get some positive statement on 1801 and sar before the AGM.
Good that shareholders can attend the AGM and ask hard and pertinent questions. Agree that the fall from July 21 to now is hard to take. The reality is that we are where we are, to coin a phrase, and that there is not a lot that the BOM can do until we get results of 1801, 737 deal and 1801 progression. I continue to be positive on the basis of the top class scientific analysis of some amazing investors on this board. I am also heartened by the patent cliff face and tremendous deal making possibilities of pharma. This has been excellently reserched and presented to us by brighty. Agree that ongoing reassurance on trial progress helps to calm the anxiety. Think SAD's resolute belief in the prospects of 1801 in relation to toxicity and effacy is a source of confidence. Many of us complain and that's OK where the posters are genuinely invested. Re.ember that we are extremely fortunate to have an array of people with scientific, financial and industry knowledge.
Common SAR.
SAD , Afham, my origional post should have included the word potential instead of apparently in relation to pharma assessing SRA 737. If the are assessing the potential of 737 based on researched data, then I thimk that it would be generally agreed on here that it's use in combo treatment would be the most promising. What the original message tried to convey was the disconnect etween the present share price of Sareum considering the huge progress made by the company in progressing 1801, SRA looking really good in combo and I could have added 1802, which is at the latter stages of preclinical and looking posit
Unfortunately that
Hard to fathom. Share price approaching the levels following the MHRA debacle with 1801 and GSK handback of 737. Meanwhile 737 is apparently being onsidered by Pharma for Combo trialling and 1801 apparently sailing through the phase 1a safety trials. Puzzle me that indeed. Sounds like bargaining.
Agree Lazarus. This board has been clear and rational in relation to the presentation. No negative soundings, 737 very much in the mix apparently, 1801 progressing well and 1802 looking like a potential blockbuster. It's a long road that has no turning and I would agree that we could have a license x2 or T/O in about a year at most with news of 737 much sooner. Its difficult to bear the chancers on here with negative agendas but good that the real investors on this board are holding strong.